The expression of ANRIL was significantly up-regulatedin the CAD+ group (fold change=2.28, P=0.012) (Fig .1).This suggests that the expression of ANRIL is associatedwith atherosclerosis susceptibility in T2DM patients. Here, CDKN2B-AS1 is linked to type 2 diabetes mellitus.